MRJ Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $1.43M | Sell |
10,593
-807
| -7% | -$95.3K | 0.83% | 39 |
|
|
2021
Q3 | $1.23M | Sell |
11,400
-220
| -2% | -$25.1K | 0.72% | 43 |
|
|
2021
Q2 | $1.31M | Hold |
11,620
| – | – | 0.76% | 41 |
|
|
2021
Q1 | $1.26M | Hold |
11,620
| – | – | 0.78% | 41 |
|
|
2020
Q4 | $1.25M | Hold |
11,620
| – | – | 0.84% | 40 |
|
|
2020
Q3 | $1.02M | Hold |
11,620
| – | – | 0.79% | 40 |
|
|
2020
Q2 | $1.14M | Hold |
11,620
| – | – | 0.97% | 39 |
|
|
2020
Q1 | $885K | Hold |
11,620
| – | – | 0.95% | 41 |
|
|
2019
Q4 | $1.03M | Hold |
11,620
| – | – | 0.58% | 47 |
|
|
2019
Q3 | $879K | Buy |
+11,620
| New | +$797K | 0.51% | 46 |
|
|
2019
Q2 | – | Sell |
-15,462
| Closed | -$1.25M | – | 53 |
|
|
2019
Q1 | $1.25M | Sell |
15,462
-25,700
| -62% | -$2.1M | 0.75% | 43 |
|
|
2018
Q4 | $3.79M | Buy |
+41,162
| New | +$3.62M | 2.59% | 18 |
|
|
2018
Q3 | – | Sell |
-43,562
| Closed | -$4.04M | – | 48 |
|
|
2018
Q2 | $4.04M | Sell |
43,562
-1,138
| -3% | -$111K | 2.24% | 23 |
|
|
2018
Q1 | $4.23M | Buy |
44,700
+2,600
| +6% | +$286K | 2.32% | 20 |
|
|
2017
Q4 | $4.07M | Sell |
42,100
-400
| -0.9% | -$37.7K | 2.18% | 24 |
|
|
2017
Q3 | $3.78M | Sell |
42,500
-900
| -2% | -$68.5K | 2.12% | 25 |
|
|
2017
Q2 | $3.15M | Sell |
43,400
-1,700
| -4% | -$114K | 1.86% | 29 |
|
|
2017
Q1 | $2.94M | Sell |
45,100
-3,900
| -8% | -$245K | 1.76% | 29 |
|
|
2016
Q4 | $3.07M | Sell |
49,000
-9,400
| -16% | -$574K | 1.96% | 24 |
|
|
2016
Q3 | $3.68M | Sell |
58,400
-5,400
| -8% | -$350K | 2.42% | 17 |
|
|
2016
Q2 | $3.95M | Sell |
63,800
-2,900
| -4% | -$177K | 2.69% | 14 |
|
|
2016
Q1 | $3.81M | Sell |
66,700
-28,400
| -30% | -$1.58M | 2.6% | 16 |
|
|
2015
Q4 | $5.63M | Sell |
95,100
-7,200
| -7% | -$415K | 3.68% | 4 |
|
|
2015
Q3 | $5.57M | Buy |
102,300
+3,700
| +4% | +$241K | 3.52% | 4 |
|
|
2015
Q2 | $6.62M | Buy |
98,600
+1,500
| +2% | +$97.9K | 3.69% | 4 |
|
|
2015
Q1 | $5.68M | Buy |
97,100
+7,500
| +8% | +$453K | 3.19% | 8 |
|
|
2014
Q4 | $5.86M | Buy |
89,600
+800
| +0.9% | +$50.4K | 3.26% | 5 |
|
|
2014
Q3 | $5.13M | Hold |
88,800
| – | – | 2.96% | 7 |
|
|
2014
Q2 | $5.01M | Buy |
88,800
+1,300
| +1% | +$68.2K | 2.89% | 8 |
|
|
2014
Q1 | $4.5M | Sell |
87,500
-4,900
| -5% | -$248K | 2.73% | 12 |
|
|
2013
Q4 | $4.88M | Sell |
92,400
-1,700
| -2% | -$83.6K | 3.07% | 8 |
|
|
2013
Q3 | $4.21M | Buy |
94,100
+600
| +0.6% | +$26.6K | 2.92% | 10 |
|
|
2013
Q2 | $3.87M | Buy |
+93,500
| New | +$4.09M | 2.77% | 14 |
|
Other funds holding ABBV
MRJ Capital's ABBV Position: Q4 2021 in Review
MRJ Capital reduced its AbbVie (ABBV) stake by 7.1% in Q4 2021, selling an estimated $95.3K and leaving 10,593 shares worth $1.43M. The position accounts for 0.83% of the portfolio, ranked #39.
MRJ Capital first reported a position in ABBV in Q2 2013 and has held it in 33 quarters since. The position peaked at $6.62M in Q2 2015. 2,981 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.
- MRJ Capital held 10,593 shares of AbbVie worth $1.43M as of Q4 2021.
- MRJ Capital sold 807 AbbVie shares in Q4 2021, an estimated $95.3K.
- AbbVie made up 0.83% of MRJ Capital's portfolio in Q4 2021, its #39 holding.
- MRJ Capital first reported a position in AbbVie in Q2 2013 and has held it in 33 quarters since.
- MRJ Capital's AbbVie position peaked at $6.62M in Q2 2015.
- 2,981 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.
Based on MRJ Capital's 13F filing for Q4 2021, filed 25 Jan 2022.